![Barbara McGovern](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Barbara McGovern formerly worked at AbbVie, Inc., as Medical Director-Medical Affairs Division and Seres Therapeutics, Inc., as Vice President-Medical Affairs from 2015 to 2024.
Dr. McGovern received her undergraduate degree from Queens College and doctorate degree from Albert Einstein College of Medicine, Inc.
Anciens postes connus de Barbara McGovern
| Sociétés | Poste | Fin |
|---|---|---|
| SERES THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 31/01/2024 |
| ABBVIE INC. | Corporate Officer/Principal | - |
Formation de Barbara McGovern
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Queens College
 Queens College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albert Einstein College of Medicine, Inc.
 Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seres Therapeutics, Inc.
 Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
